Top Pharma Companies & Drugs in 2024: Merck’s Keytruda maintains top spot as Novo’s semaglutide nips at its heels

Data Compilation
#PharmaFlow

Pipeline Prospector March 2025: Trump’s FDA overhaul spooks biotech stocks; Roche, AbbVie, Novo ink obesity drug deals

Stock Recap
#PipelineProspector

Clindagel

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

41 API Suppliers, 18 USDMF, 12 CEP/COS, 6 JDMF, 1 EU WC, 2 KDMF, 13 NDC API, 17 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

20 Drugs in Development

20 Drugs in Development

INTERMEDIATES

1 Intermediate Suppliers

1 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

169 FDF Dossiers, 133 FDA Orange Book, 10 Europe, 16 Canada, 1 South Africa, 9 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SOLUTION;INTRAVENOUS - EQ 300MG BASE/50ML (EQ 6MG BASE/ML), SOLUTION;INTRAVENOUS - EQ 600MG BASE/50ML (EQ 12MG BASE/ML), SOLUTION;INTRAVENOUS - EQ 900MG BASE/50ML (EQ 18MG BASE/ML), INJECTABLE;INJECTION - EQ 150MG BASE/ML, SOLUTION;TOPICAL - EQ 1% BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, LOTION;TOPICAL - EQ 1% BASE, GEL;TOPICAL - EQ 1% BASE, GEL;TOPICAL - 5%;1.2%, GEL;TOPICAL - 5%;EQ 1% BASE, SUPPOSITORY;VAGINAL - 100MG, GEL;TOPICAL - EQ 1% BASE, CREAM;VAGINAL - EQ 2% BASE, AEROSOL, FOAM;TOPICAL - 1% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, GEL;TOPICAL - 1.2%;0.025%

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 2 Rochem International Inc, 3 SPI Pharma, 5 DKSH, 1 Pharm-RX Chemical, 1 Gangwal Healthcare, 10 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 8 Actylis, 1 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 13 BASF, 1 BioSpectra, 1 Clariant, 6 Corel Pharma Chem, 2 Finar, 7 Gangwal Chemicals, 8 Kerry, 5 Lubrizol Life Science Health, 4 Microlex e.U, 1 Nanjing Bold Chemical, 2 Pluviaendo, 16 Roquette, 10 Seppic, 1 Shijiazhuang Huaxu Pharmaceutical, 1 Sigachi Industries, 1 Valens Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

37 Topical, 24 Solubilizers, 23 Parenteral, 23 Thickeners and Stabilizers, 16 Film Formers & Plasticizers, 14 Emulsifying Agents, 13 Fillers, Diluents & Binders, 9 Coating Systems & Additives, 8 Co-Processed Excipients, 8 Surfactant & Foaming Agents, 7 Direct Compression, 7 Controlled & Modified Release, 6 Rheology Modifiers, 6 Lubricants & Glidants, 5 Taste Masking, 4 Granulation, 3 API Stability Enhancers, 2 Chewable & Orodispersible Aids, 1 Soft Gelatin

DIGITAL CONTENT

1 Data Compilation #PharmaFlow, 56 News #PharmaBuzz

GLOBAL SALES INFORMATION

4 US Medicaid Prescriptions, 9 Regulatory FDF Prices

MARKET PLACE

32 APIs, 4 FDF Dossiers

PATENTS & EXCLUSIVITIES

21 US Patents, 2 US Exclusivities

REF. STANDARDS & IMPURITIES

3 EDQM, 1 USP, 2 Others

$ Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Registrant Name	Registration No.	Compound	Registration Date	Manufacturer	Manufacturer's Country	Manufacturer's Address
28/03/2025	Zhejiang Hisoar Pharmaceutical	China	Ace Biopharm Co., Ltd.	20210209-210-J-618	Phosphate clindamycin	2021-02-09	Zhejiang Hisoar Chuannan Pharmaceutical Co., Ltd.	China	No. 23 Donghai 5th Avenue, Zhejiang Chemical Materials Base Linhai Zone, Linhai City, Zhejiang Province China
28/03/2025			Sampoong Finechem Co., Ltd.		Clindamycin phosphate	2025-03-26	Zhejiang Tiantai Pharmaceutical Co., Ltd.@HEC Pharm Co., Ltd	China	No. 9, Cangshan Road, Sanhe Town, Tiantai County, Taizhou City, Zhejiang Province, China (317207)@No. 3 Industrial Park of HEC, Yidu City, Hubei Province, China

Clindagel

Clindagel

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

41 API Suppliers

18 USDMF

12 CEP/COS

6 JDMF

1 EU WC

2 KDMF

13 NDC API

17 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

20 Drugs in Development

INTERMEDIATES

1 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

169 FDF Dossiers

133 FDA Orange Book

10 Europe

16 Canada

1 South Africa

9 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SOLUTION;INTRAVENOUS - EQ 300MG BASE/50ML (EQ 6MG BASE/ML)

SOLUTION;INTRAVENOUS - EQ 600MG BASE/50ML (EQ 12MG BASE/ML)

SOLUTION;INTRAVENOUS - EQ 900MG BASE/50ML (EQ 18MG BASE/ML)

INJECTABLE;INJECTION - EQ 150MG BASE/ML

SOLUTION;TOPICAL - EQ 1% BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

LOTION;TOPICAL - EQ 1% BASE

GEL;TOPICAL - EQ 1% BASE

GEL;TOPICAL - 5%;1.2%

GEL;TOPICAL - 5%;EQ 1% BASE

SUPPOSITORY;VAGINAL - 100MG

GEL;TOPICAL - EQ 1% BASE

CREAM;VAGINAL - EQ 2% BASE

AEROSOL, FOAM;TOPICAL - 1% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

GEL;TOPICAL - 1.2%;0.025%

RELATED EXCIPIENT COMPANIES

2 EUROAPI

2 Rochem International Inc

3 SPI Pharma

5 DKSH

1 Pharm-RX Chemical

1 Gangwal Healthcare

10 Nanjing Well Pharmaceutical

1 Pfanstiehl

8 Actylis

1 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

13 BASF

1 BioSpectra

1 Clariant

6 Corel Pharma Chem

2 Finar

7 Gangwal Chemicals

8 Kerry

5 Lubrizol Life Science Health

4 Microlex e.U

1 Nanjing Bold Chemical

2 Pluviaendo

16 Roquette

10 Seppic

1 Shijiazhuang Huaxu Pharmaceutical

1 Sigachi Industries

1 Valens Pharmachem

1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

37 Topical

24 Solubilizers

23 Parenteral

23 Thickeners and Stabilizers

16 Film Formers & Plasticizers

14 Emulsifying Agents

13 Fillers, Diluents & Binders

9 Coating Systems & Additives

8 Co-Processed Excipients

SOLUTION;TOPICAL - EQ 1% BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

AEROSOL, FOAM;TOPICAL - 1% Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons